首页|期刊导航|肿瘤学与转化医学（英文）|The expression of vascular endothelial growth factor (VEGF)/ endostatin (ES) and VEGF receptor 2 (VEGFR2)/ES is associated with NSCLC prognosis

The expression of vascular endothelial growth factor (VEGF)/ endostatin (ES) and VEGF receptor 2 (VEGFR2)/ES is associated with NSCLC prognosis

Yuan Yang Baohua Lu Baolan Li Weiying Li Mei Jiang Wentao Yue Qunhui Wang Tongmei Zhang

肿瘤学与转化医学（英文）2021，Vol.7Issue(4)：149-154,6.

肿瘤学与转化医学（英文）2021，Vol.7Issue(4)：149-154,6.DOI:10.1007/s10330-020-0407-7

The expression of vascular endothelial growth factor (VEGF)/ endostatin (ES) and VEGF receptor 2 (VEGFR2)/ES is associated with NSCLC prognosis

Yuan Yang ¹Baohua Lu ¹Baolan Li ¹Weiying Li ²Mei Jiang ²Wentao Yue ²Qunhui Wang ¹Tongmei Zhang¹

作者信息

1. General Department of Medicine,Beijing Chest Hospital,Capital Medical University,Beijing 101149,China
2. Laboratory of Cell Biotechnology,Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149,China
折叠

摘要

关键词

non-small cell lung cancer (NSCLC)/angiogenesis/clinical characteristics/prognosis

Key words

non-small cell lung cancer (NSCLC)/angiogenesis/clinical characteristics/prognosis

引用本文复制引用

Yuan Yang,Baohua Lu,Baolan Li,Weiying Li,Mei Jiang,Wentao Yue,Qunhui Wang,Tongmei Zhang..The expression of vascular endothelial growth factor (VEGF)/ endostatin (ES) and VEGF receptor 2 (VEGFR2)/ES is associated with NSCLC prognosis[J].肿瘤学与转化医学（英文）,2021,7(4):149-154,6.

基金项目

Supported by the Natural Science Foundation of China(No.81602531). （No.81602531）

肿瘤学与转化医学（英文）

OACSTPCD

ISSN：2095-9621

访问量3

下载量0

段落导航